Major Developments:

Qyuns Therapeutics-B (02509): Breakthrough research results from the Phase III clinical study of Otokibart (QX005N) for prurigo nodularis were presented as an oral breakthrough research report at EADV 2026.

Change in Controlling Shareholding: KFM Gold (03816) has been acquired by Luxshare Precision (02475) for a 57.0% stake, with a cash offer made; trading resumes on October 2.

Conch Cement (00914)'s subsidiaries have acquired equity in several companies for a total of 307 million yuan, expanding into the medical waste treatment market in Northeast China and the Bohai Rim region.

FORTIOR (01304)'s subsidiary plans to acquire all shares of Sciosense B.V. for USD 95,783,300.

China Technology Group (01725)'s subsidiary plans to sell all shares of Steady Elite Limited for HKD 3,696,000.

Insilico Medicine (03696) has nominated a new generation small molecule GIPR antagonist, potentially for intervention in obesity and related diseases.

Operating Results:

BYD Company (01211) September auto sales were approximately 463,600 units, up 16.98% year-on-year.

Geely Automobile (00175) September total auto sales were 292,168 units, up approximately 7% year-on-year.

Voyah Automobile (07489) delivered 115,481 new vehicles in the first nine months, up 19% year-on-year.

Great Wall Motor (02333) September total auto sales were approximately 114,900 units, down 13.99% year-on-year.

Li Auto-W (02015) delivered 31,817 new vehicles in September.

VALA (02051): In the third quarter, a total of 420 vala vehicles were delivered to ordering customers.